A clinical-stage biotechnology company focused on developing gene and cell therapies for cancer, with research centered on engineered immune cells and controlled gene expression platforms. Its pipeline has historically targeted solid tumors and hematologic malignancies through early‑stage clinical p...
This page tracks all publicly disclosed congressional trades in ZIOPHARM Oncology, Inc. (ZIOP), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 0 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-18 | Mark R Warner | sell | $250K – $500K |